Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

ClinicalTrials.gov ID: NCT02960022

Public ClinicalTrials.gov record NCT02960022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 8, 2026, 10:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Study identification

NCT ID
NCT02960022
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Global Development, Inc.
Industry
Enrollment
900 participants

Conditions and interventions

Interventions

  • Leuprolide acetate Drug
  • abiraterone acetate Drug
  • enzalutamide Drug
  • prednisone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2016
Primary completion
Jul 30, 2029
Completion
Jul 30, 2029
Last update posted
Apr 12, 2026

2016 – 2029

United States locations

U.S. sites
50
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Site US10052 Anchorage Alaska 99503 Completed
Site US10011 Tucson Arizona 85741 Completed
Site US10040 Los Angeles California 90024 Completed
Site US10009 Los Angeles California 90048 Completed
Site US10067 Orange California 92868 Recruiting
Site US10008 San Bernardino California 92404 Completed
Site US10042 San Diego California 92108 Completed
Site US10028 Stanford California 94305 Completed
Site US10001 Aurora Colorado 80045 Completed
Site US10017 Denver Colorado 80211 Completed
Site US10050 Washington D.C. District of Columbia 20037 Completed
Site US10049 Daytona Beach Florida 32114 Completed
Site US10048 Jacksonville Florida 32216 Withdrawn
Site US10002 Chicago Illinois 60637 Active, not recruiting
Springfield Clinic, LLP Springfield Illinois 62701 Active, not recruiting
Site US10007 Jeffersonville Indiana 47130 Completed
University of Kansas Medical Center Kansas City Kansas 66160 Active, not recruiting
Site US10066 Lenexa Kansas 66214-1656 Active, not recruiting
Site US10029 Towson Maryland 21204 Completed
Site US10032 St Louis Missouri 63110 Completed
Nebraska Medical Hospital Omaha Nebraska 68114 Active, not recruiting
Site US10023 Omaha Nebraska 68130 Active, not recruiting
Site US10004 Hackensack New Jersey 07601 Active, not recruiting
Site US10024 Garden City New York 11530 Active, not recruiting
Site US10055 New York New York 10065 Completed
Site US10059 New York New York 10065 Completed
Hudson Valley Urology, PC Poughkeepsie New York 12601 Active, not recruiting
Site US10053 Syracuse New York 13210 Completed
Site US10030 Chapel Hill North Carolina 27599 Completed
Site US10062 Charlotte North Carolina 28207 Active, not recruiting
Site US10020 Concord North Carolina 28025 Withdrawn
Site US10031 Greensboro North Carolina 27403 Terminated
Eastern Urological Associates Greenville North Carolina 27834 Completed
Site US10046 Winston-Salem North Carolina 27157 Completed
Site US10035 Cincinnati Ohio 45212 Completed
Site US10022 Springfield Oregon 97477 Completed
Site US10027 Lancaster Pennsylvania 17604 Completed
Site US10005 Pittsburgh Pennsylvania 15232 Active, not recruiting
Site US10018 Charleston South Carolina 29414 Active, not recruiting
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 Active, not recruiting
Site US10003 Myrtle Beach South Carolina 29572 Withdrawn
Site US10041 Nashville Tennessee 37232-2765 Active, not recruiting
Site US10010 Dallas Texas 75231 Active, not recruiting
Site US10034 Houston Texas 77024 Completed
Site US10043 Houston Texas 77030 Active, not recruiting
Site US10014 Norfolk Virginia 23502 Completed
Site US10015 Virginia Beach Virginia 23462 Active, not recruiting
Virginia Mason Medical Center Seattle Washington 98101 Active, not recruiting
Site US10038 Seattle Washington 98109 Completed
Site US10021 Madison Wisconsin 53792 Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 191 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02960022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02960022 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →